Formulation and evaluation of oral sustained release of Diltiazem Hydrochloride using rosin as matrix forming material

Ars Pharmaceutica

Volumn 50, Issue 1, 2009, Pages 32-42

  Lakshmana Prabu, S ^a   Shirwaikar, A A ^a   Shirwaikar, A ^a   Ravikumar, G ^a   Kumar, A ^a   Jacob, A ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Compatibility; Differential scanning calorimetry; Diltiazem hydrochloride; FTIR; HPTLC; Rosin; Sustained release matrix; Tablet excipients

Indexed keywords

DILTIAZEM; ROSIN;

ARTICLE; COMPRESSION; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; HARDNESS; KINETICS; MATRIX TABLET; SUSTAINED DRUG RELEASE; THICKNESS; WEIGHT;

EID: 70349666783     PISSN: 00042927     EISSN: 00042927     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. rd ed. Varghese Publishing House, Bombay, 1986; p. 430-456.
2. Thomas WYL, Joseph RR. Controlled release drug delivery systems. In Gennaro AR. Remington: The Science and Practice of Pharmacy, Lippincott Williams and Wilkins, Philadelphia, 2000; p. 903-906.
3. Baveja SR, Ranga RKV, Arora J. Examination of natural gums and mucilages as sustaining materials in tablet dosage forms. J Pharm Sci 1989; 51(4): 115-118. (Pubitemid 20081275)
4. Kakkar AP, Singh M, Medirrata A. Formulation optimization of diltiazem Hydrochloride matrix tablets containing modified isphagula husk using factorial design. Drug Dev Ind Pharm 1997; 23(11): 1055-1061.
5. Sheorey DS, Dorle AK. Effect of solvents on the characteristics of rosin walled microcapsules prepared by a solvent evaporation technique. J Microencapsul 1991; 8(1): 71-78.
6. Sheorey DS, Dorle AK. Rosin coacervate microcapsules: effect of solvent on phase separation of rosin. J Microencapsul 1993; 10(2): 209-214.
7. Shirwaikar AA, Reddy N. Rosin, a polymer for micro encapsulation of Diltiazem Hydrochloride for sustained release by emulsion solvent evaporation technique. Ind J Pharm Sci 2000; 62(4): 308-310.
8. Pathak YV, Dorle AK. Rosin and rosin derivatives as hydrophobic matrix materials for controlled release of drugs, Drug Dev Ind Pharm 1990; 6(3): 223-227.
9. Ramani CC, Puranik PK, Dorle AK. Study of maleoabietic acid as matrix forming material. Int J Pharm 1996; 1: 344-352.
10. Satturwar PM, Fulzele SV, Mandaogade PM, Mundhada DR, Gogte BB, Dorle AK. Evaluation of new rosin derivative for pharmaceutical coating. Int J Pharm 2004; 270 (1-2): 27-36.
11. Fulzele SV, Satturwar PM, Dorle AK. Polymerized rosin: novel film forming polymer for drug delivery. Int. J. Pharm 2002; 249(1-2): 175-184. (Pubitemid 35333444)
12. Satturwar PM, Fulzele SV, Dorle AK. Evaluation of polymerized rosin for the formulationand evelopment of transdermal drug delivery system. A technical note. AAPSPharmSciTech, 2005; 6(4): article 81.
13. Fulzele SV, Satturwar PM, Dorle AK. Study of the biodegradation and in vivo bio compatibility of novel biomaterials. Eur J Pharm Sci 2003; 20(1): 53-61.
14. Satturwar PM, Fulzele SV, Dorle AK. Biodegradation studies of rosin based polymer. Drug Dev Ind Pharm 2003; 29(6): 669-677.
15. Chaffman M, Brogden RN. Diltiazem: A review of its pharmacological properties and therapeutic efficacy. Drugs 1985; 29(5): 387-454. (Pubitemid 15056469)
16. Kim H, Fassihi R. New ternary polymeric matrix system for control drug delivery of highly soluble drugs. Pharm Res 1997; 14: 1415-1421.
17. Logannathan V, Senthil Kumar K, Siva Prasada Reddy MV, Sreekanth N, Senthil Kumar B. Studies on preformulation compatibility between lomefloxacin and tablet excipients through DSC and X-ray diffraction analysis. Int Journal of Pharmaceutical Excipients April-June, 2003; 38-49.
18. Bristish Pharmacopoeia Commission. British Pharmacopoeia Addendum 1996. London, UK: British Pharmacopoeia Commission, 1996; p. 658.
19. rd ed. Varghese publishing house, Mumbai, 1987; p. 383.